Opportunity ID: 281413

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 5
Posted Date: Feb 07, 2016
Last Updated Date: Mar 15, 2021
Original Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Kathleen Sobush
ghk5@cdc.gov
Email:ghk5@cdc.gov

Version History

Version Modification Description Updated Date
EPI language Mar 15, 2021
Amendment I Feb 07, 2016
To clarify time of application due date. Feb 07, 2016
This modification is to correctly upload the FOA document, correct point of contact, and correct FOA due date. Mar 14, 2016
Mar 14, 2016

DISPLAYING: Synopsis 5

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 5
Posted Date: Feb 07, 2016
Last Updated Date: Mar 15, 2021
Original Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Kathleen Sobush
ghk5@cdc.gov
Email:ghk5@cdc.gov

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Feb 07, 2016
Last Updated Date: Apr 24, 2020
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Kathleen Sobush
ghk5@cdc.gov
Email:ghk5@cdc.gov

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Feb 07, 2016
Last Updated Date: Mar 14, 2016
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Office of Grant Services, OGSTIMS
Email:ogstims@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 14, 2016
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 07, 2016
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Office of Grant Services, OGSTIMS
Email:ogstims@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH16-1641
Funding Opportunity Title: Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 14, 2016
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 07, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: May 07, 2016
Estimated Total Program Funding: $0
Award Ceiling: $2,292,104
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Namibian Institute of Pathology

Additional Information

Agency Name: Centers for Disease Control – CGH
Description: To strengthen community-based interventions for HIV/AIDS prevention, care and treatment in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR). The grantee will improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB) as well as expand its capacity to provide quality services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia including laboratory monitoring of antiretroviral (ARV) treatment outcome and related diagnostics.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Kathleen Sobush
ghk5@cdc.gov

Email:ghk5@cdc.gov

Folder 281413 Full Announcement-FULL_ANNOUNCEMENT -> GH16-1641 amendment I EPI language.pdf

Folder 281413 Full Announcement-GH16-1641 -> gh16-1641 namibia pepfar.pdf

Folder 281413 Revised Full Announcement-REVISED_FULL_ANNOUNCEMENT -> Epicemic control information.pdf

Packages

Agency Contact Information: Kathleen Sobush
ghk5@cdc.gov
Email: ghk5@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.067 CDC-RFA-GH16-1641 Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR) PKG00220831 Feb 07, 2016 Apr 07, 2016 View

Package 1

Mandatory forms

281413 SF424_2_1-2.1.pdf

281413 SF424A-1.0.pdf

281413 HHS_CheckList_2_1-2.1.pdf

281413 Project-1.1.pdf

281413 Budget-1.1.pdf

Optional forms

281413 Other-1.1.pdf

2025-07-09T09:01:56-05:00

Share This Post, Choose Your Platform!

About the Author: